CN Stock MarketDetailed Quotes

603896 Zhejiang Shouxiangu Pharmaceutical

Watchlist
  • 23.07
  • +0.14+0.61%
Not Open Nov 12 15:00 CST
4.57BMarket Cap19.57P/E (TTM)

Zhejiang Shouxiangu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-39.27%861.8M
-35.42%1.1B
-0.16%1.62B
-1.36%1.5B
45.60%1.42B
112.04%1.7B
130.18%1.62B
124.89%1.52B
70.23%974.62M
14.06%800.04M
Transactional financial assets
--302.17M
--270M
----
----
----
----
-73.33%30M
-76.92%30M
-82.35%30M
-45.45%30M
Notes receivable and accounts receivable
2.40%122.28M
12.60%123.24M
29.50%164.35M
-18.68%111.93M
90.55%119.41M
90.60%109.44M
43.23%126.92M
62.86%137.65M
14.08%62.67M
34.98%57.42M
-Notes receivable
113.78%30.52M
4.33%25.04M
-50.50%18.94M
-13.10%20.84M
--14.28M
--24M
--38.27M
--23.99M
----
----
-Accounts receivable
-12.72%91.76M
14.93%98.2M
64.03%145.41M
-19.86%91.09M
67.76%105.13M
48.81%85.44M
0.04%88.65M
34.48%113.66M
14.08%62.67M
34.98%57.42M
Other receivables (including interest and dividends)
8.19%4.29M
-29.94%4.07M
28.83%4.6M
29.63%3.25M
9.87%3.97M
64.30%5.81M
0.97%3.57M
-14.07%2.51M
-1.99%3.61M
5.79%3.54M
-Other receivable
----
-29.94%4.07M
----
----
----
64.30%5.81M
----
-14.07%2.51M
----
5.79%3.54M
Advance payment
34.54%17.41M
-27.81%10.4M
-20.56%12.07M
47.91%20.66M
-12.45%12.94M
16.91%14.4M
40.25%15.19M
32.11%13.97M
26.09%14.78M
23.19%12.32M
Inventories
21.01%217.21M
11.73%207.03M
0.93%166.39M
6.82%157.83M
3.61%179.5M
8.29%185.29M
26.44%164.85M
49.16%147.76M
21.42%173.25M
15.57%171.11M
Receivable financing
49.56%603.42K
-9.78%329K
346.51%1.38M
3,396.58%1.13M
-95.13%403.46K
-95.89%364.68K
-99.00%309.08K
-99.90%32.37K
-27.08%8.29M
-35.12%8.88M
Other current assets
11.01%8.67M
318.80%10.75M
220.27%12.04M
49.88%8.08M
-6.34%7.81M
-73.57%2.57M
22.89%3.76M
-28.28%5.39M
203.11%8.33M
399.59%9.72M
Adjustment items of current assets
----
----
--0.01
----
----
----
----
----
----
----
Total current assets
-11.97%1.53B
-14.55%1.72B
0.69%1.98B
-2.96%1.81B
36.65%1.74B
84.28%2.01B
81.37%1.97B
78.13%1.86B
31.54%1.28B
11.99%1.09B
Non Current assets
Other equity investment
31.69%82.59M
19.50%75.14M
14.98%72.56M
6.39%59.98M
14.67%62.71M
-1.49%62.88M
-0.35%63.11M
-4.26%56.37M
-10.95%54.69M
-1.81%63.83M
Other non-current financial assets
----
----
----
----
--0
----
-45.65%1.5M
-45.65%1.5M
-90.06%1.5M
-90.06%1.5M
Investment real estate
-5.09%215.54M
-5.03%218.49M
-5.26%220.8M
15.12%223.76M
15.37%227.08M
15.44%230.06M
15.51%233.05M
-4.81%194.38M
-4.76%196.84M
-4.06%199.3M
Long-term equity investment
-15.47%4.66M
4.76%5.71M
-1.54%5.9M
-3.20%5.74M
-6.93%5.51M
-8.78%5.45M
-4.59%5.99M
23.03%5.93M
12.04%5.92M
11.54%5.97M
Fixed assets
----
-7.77%320.64M
----
----
----
0.21%347.67M
----
5.45%376.95M
----
-3.73%346.94M
Constru in process
----
176.79%400.07M
----
----
----
-7.40%144.54M
----
47.07%169.63M
----
1,791.18%156.09M
Productive biological assets
-8.19%28.03M
-11.95%29.5M
-1.98%34.84M
4.01%31.38M
12.20%30.53M
24.27%33.51M
37.86%35.55M
34.64%30.17M
73.70%27.21M
32.01%26.96M
Intangible assets
13.41%355.83M
-5.86%89.26M
-8.35%87.76M
297.88%310.98M
296.38%313.77M
17.98%94.81M
17.20%95.76M
-5.81%78.16M
-5.60%79.16M
4.33%80.36M
Long deferred expense
38.13%63.36M
44.75%70.19M
49.85%75.31M
50.15%79.78M
3.14%45.87M
32.72%48.49M
37.27%50.26M
33.07%53.13M
29.29%44.47M
1.36%36.54M
Deferred tax assets
----
----
----
----
----
----
----
----
-0.32%311.98K
-81.06%278.3K
Usufruct assets
16.27%41.01M
6.91%39.77M
42.91%34.46M
46.49%35.72M
74.10%35.27M
95.15%37.2M
20.11%24.11M
17.77%24.38M
16.48%20.26M
2.13%19.06M
Other non current assets
-76.60%2.83M
1,691.46%136.64M
804.28%60.65M
38.97%4.95M
-13.90%12.08M
-55.47%7.63M
-67.46%6.71M
-51.18%3.56M
-56.72%14.03M
-2.50%17.13M
Total non current assets
23.17%1.52B
36.87%1.39B
22.34%1.24B
37.55%1.37B
28.71%1.23B
6.11%1.01B
7.21%1.02B
8.40%994.18M
12.25%958.86M
14.52%953.96M
Total assets
2.60%3.05B
2.65%3.11B
8.06%3.23B
11.14%3.17B
33.24%2.98B
47.85%3.03B
46.81%2.98B
45.54%2.86B
22.51%2.23B
13.15%2.05B
Liabilities
Current liabilities
Short term loan
-41.00%195.87M
-33.02%246.18M
15.18%394.23M
36.34%372.16M
74.74%332M
--367.52M
--342.27M
--272.97M
--190M
----
Notes payable and accounts payable
4.02%121.48M
2.78%167.84M
-33.47%97.08M
1.29%145.82M
-24.72%116.79M
-16.08%163.3M
-11.61%145.92M
2.24%143.96M
14.55%155.14M
19.81%194.6M
-Accounts payable
4.02%121.48M
2.78%167.84M
-33.47%97.08M
1.29%145.82M
-24.72%116.79M
-16.08%163.3M
-11.61%145.92M
2.24%143.96M
14.55%155.14M
19.81%194.6M
Contract liabilities
12.89%11.36M
11.47%9.7M
20.18%10.55M
8.37%8.98M
26.66%10.06M
-3.39%8.7M
-16.19%8.78M
-2.85%8.28M
-28.42%7.94M
4.09%9.01M
Advance receipts
50.57%1.18M
27.93%1.45M
-17.11%1.35M
50.17%1.13M
-66.79%780.61K
-32.24%1.13M
132.81%1.63M
-30.40%751.68K
--2.35M
--1.67M
Salaries payable
-12.81%26M
-8.70%22.42M
-4.05%18.42M
-9.32%29.09M
3.83%29.81M
5.02%24.56M
7.03%19.2M
13.50%32.08M
21.10%28.71M
23.26%23.38M
Taxs payable
-3.08%8.4M
-2.50%3.4M
48.05%6.98M
16.01%9.53M
7.50%8.67M
-60.63%3.49M
37.04%4.71M
100.04%8.22M
-25.21%8.06M
155.51%8.86M
Other payable (including interest and dividends)
-0.58%2.74M
-92.55%2.84M
184.51%7.32M
-6.35%5.36M
-56.13%2.76M
231.80%38.1M
-55.30%2.57M
-42.18%5.73M
0.77%6.29M
40.59%11.48M
-Dividend payable
----
----
----
----
----
--35.07M
----
----
----
----
-Other payable
----
-6.45%2.84M
----
----
----
-73.59%3.03M
----
-42.18%5.73M
----
65.35%11.48M
Non current liabilities due within one year
6.28%10.43M
5.94%10.68M
44.81%7.92M
147.88%12.08M
66.50%9.81M
91.89%10.09M
7.99%5.47M
-13.48%4.87M
59.52%5.89M
39.32%5.26M
Other current liabilities
6.94%1.2M
9.57%1.07M
16.18%1.15M
9.90%1M
29.13%1.12M
-3.91%974.38K
-14.92%986.58K
-4.96%910K
-19.67%865.64K
-96.35%1.01M
Total current liabilities
-26.02%378.65M
-24.65%465.58M
2.53%545.01M
22.48%585.15M
26.29%511.8M
142.03%617.86M
153.56%531.55M
139.75%477.77M
111.03%405.26M
9.46%255.28M
Current liabilities
Bonds payable
6.46%358.05M
6.46%352.01M
-17.54%346.05M
-17.55%340.19M
269.06%336.33M
269.41%330.64M
372.79%419.67M
371.00%412.59M
0.83%91.13M
-15.06%89.51M
Deferred tax liabilities
76.24%7.07M
45.53%6.02M
30.57%5.4M
24.10%3.78M
16.66%4.01M
-13.81%4.13M
2.10%4.14M
-23.50%3.04M
-21.28%3.44M
-2.19%4.8M
Long term deferred income
18.13%50.6M
25.36%49.31M
12.77%46.11M
21.03%49.98M
19.51%42.83M
0.51%39.33M
17.61%40.89M
8.04%41.3M
76.73%35.84M
82.50%39.13M
Lease liabilities
19.54%28.21M
4.29%26.04M
62.08%23.81M
50.09%23.97M
104.68%23.6M
122.23%24.96M
27.92%14.69M
19.81%15.97M
-7.53%11.53M
-13.19%11.23M
Total non current liabilities
9.14%443.94M
8.59%433.37M
-12.10%421.38M
-11.63%417.92M
186.58%406.78M
175.85%399.07M
244.71%479.4M
230.39%472.9M
11.33%141.94M
0.01%144.67M
Total liabilities
-10.45%822.58M
-11.60%898.96M
-4.41%966.39M
5.51%1B
67.87%918.58M
154.27%1.02B
189.91%1.01B
177.64%950.67M
71.25%547.2M
5.84%399.95M
Shareholders equity
Paid-in capital
-1.78%198.24M
0.00%201.83M
2.34%201.83M
2.35%201.83M
2.35%201.83M
2.35%201.83M
29.30%197.21M
29.32%197.2M
29.46%197.2M
30.06%197.2M
Other equity instruments
-0.00%69.77M
-0.00%69.77M
-21.30%69.77M
-21.30%69.77M
269.98%69.77M
269.99%69.77M
369.69%88.65M
367.54%88.66M
-5.33%18.86M
-20.25%18.86M
Capital reserve funds
-16.72%804.52M
0.00%966.03M
12.81%966.03M
12.82%966.03M
12.84%966.03M
12.84%966.02M
-4.93%856.3M
-4.89%856.25M
-4.35%856.12M
-2.19%856.12M
Surplus reserve funds
8.90%100.93M
8.90%100.93M
8.90%100.93M
8.90%100.93M
19.92%92.68M
19.92%92.68M
19.92%92.68M
19.92%92.68M
15.18%77.29M
15.18%77.29M
Retained profit
17.08%1.02B
21.93%998.33M
19.76%1.05B
19.49%974.77M
26.98%867.9M
28.86%818.78M
30.58%878.38M
32.93%815.77M
33.99%683.52M
32.91%635.4M
Less:Treasury stock
----
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.12%165.11M
-13.96%165.11M
Other composite income
66.15%42.29M
40.48%35.96M
30.91%33.76M
14.91%23.06M
34.35%25.45M
-4.24%25.6M
-4.39%25.79M
-9.20%20.07M
-21.85%18.94M
-2.09%26.73M
Shareholders equity without minority interests
8.42%2.23B
9.86%2.21B
14.45%2.26B
13.95%2.17B
22.04%2.06B
22.05%2.01B
17.22%1.97B
17.65%1.91B
12.17%1.69B
15.05%1.65B
Minority interests
----
----
----
----
----
----
----
----
-24.53%388.55K
--547.48K
Total shareholder equity
8.42%2.23B
9.86%2.21B
14.45%2.26B
13.95%2.17B
22.01%2.06B
22.01%2.01B
17.18%1.97B
17.62%1.91B
12.15%1.69B
15.08%1.65B
Total liabilityies and equity
2.60%3.05B
2.65%3.11B
8.06%3.23B
11.14%3.17B
33.24%2.98B
47.85%3.03B
46.81%2.98B
45.54%2.86B
22.51%2.23B
13.15%2.05B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -39.27%861.8M-35.42%1.1B-0.16%1.62B-1.36%1.5B45.60%1.42B112.04%1.7B130.18%1.62B124.89%1.52B70.23%974.62M14.06%800.04M
Transactional financial assets --302.17M--270M-----------------73.33%30M-76.92%30M-82.35%30M-45.45%30M
Notes receivable and accounts receivable 2.40%122.28M12.60%123.24M29.50%164.35M-18.68%111.93M90.55%119.41M90.60%109.44M43.23%126.92M62.86%137.65M14.08%62.67M34.98%57.42M
-Notes receivable 113.78%30.52M4.33%25.04M-50.50%18.94M-13.10%20.84M--14.28M--24M--38.27M--23.99M--------
-Accounts receivable -12.72%91.76M14.93%98.2M64.03%145.41M-19.86%91.09M67.76%105.13M48.81%85.44M0.04%88.65M34.48%113.66M14.08%62.67M34.98%57.42M
Other receivables (including interest and dividends) 8.19%4.29M-29.94%4.07M28.83%4.6M29.63%3.25M9.87%3.97M64.30%5.81M0.97%3.57M-14.07%2.51M-1.99%3.61M5.79%3.54M
-Other receivable -----29.94%4.07M------------64.30%5.81M-----14.07%2.51M----5.79%3.54M
Advance payment 34.54%17.41M-27.81%10.4M-20.56%12.07M47.91%20.66M-12.45%12.94M16.91%14.4M40.25%15.19M32.11%13.97M26.09%14.78M23.19%12.32M
Inventories 21.01%217.21M11.73%207.03M0.93%166.39M6.82%157.83M3.61%179.5M8.29%185.29M26.44%164.85M49.16%147.76M21.42%173.25M15.57%171.11M
Receivable financing 49.56%603.42K-9.78%329K346.51%1.38M3,396.58%1.13M-95.13%403.46K-95.89%364.68K-99.00%309.08K-99.90%32.37K-27.08%8.29M-35.12%8.88M
Other current assets 11.01%8.67M318.80%10.75M220.27%12.04M49.88%8.08M-6.34%7.81M-73.57%2.57M22.89%3.76M-28.28%5.39M203.11%8.33M399.59%9.72M
Adjustment items of current assets ----------0.01----------------------------
Total current assets -11.97%1.53B-14.55%1.72B0.69%1.98B-2.96%1.81B36.65%1.74B84.28%2.01B81.37%1.97B78.13%1.86B31.54%1.28B11.99%1.09B
Non Current assets
Other equity investment 31.69%82.59M19.50%75.14M14.98%72.56M6.39%59.98M14.67%62.71M-1.49%62.88M-0.35%63.11M-4.26%56.37M-10.95%54.69M-1.81%63.83M
Other non-current financial assets ------------------0-----45.65%1.5M-45.65%1.5M-90.06%1.5M-90.06%1.5M
Investment real estate -5.09%215.54M-5.03%218.49M-5.26%220.8M15.12%223.76M15.37%227.08M15.44%230.06M15.51%233.05M-4.81%194.38M-4.76%196.84M-4.06%199.3M
Long-term equity investment -15.47%4.66M4.76%5.71M-1.54%5.9M-3.20%5.74M-6.93%5.51M-8.78%5.45M-4.59%5.99M23.03%5.93M12.04%5.92M11.54%5.97M
Fixed assets -----7.77%320.64M------------0.21%347.67M----5.45%376.95M-----3.73%346.94M
Constru in process ----176.79%400.07M-------------7.40%144.54M----47.07%169.63M----1,791.18%156.09M
Productive biological assets -8.19%28.03M-11.95%29.5M-1.98%34.84M4.01%31.38M12.20%30.53M24.27%33.51M37.86%35.55M34.64%30.17M73.70%27.21M32.01%26.96M
Intangible assets 13.41%355.83M-5.86%89.26M-8.35%87.76M297.88%310.98M296.38%313.77M17.98%94.81M17.20%95.76M-5.81%78.16M-5.60%79.16M4.33%80.36M
Long deferred expense 38.13%63.36M44.75%70.19M49.85%75.31M50.15%79.78M3.14%45.87M32.72%48.49M37.27%50.26M33.07%53.13M29.29%44.47M1.36%36.54M
Deferred tax assets ---------------------------------0.32%311.98K-81.06%278.3K
Usufruct assets 16.27%41.01M6.91%39.77M42.91%34.46M46.49%35.72M74.10%35.27M95.15%37.2M20.11%24.11M17.77%24.38M16.48%20.26M2.13%19.06M
Other non current assets -76.60%2.83M1,691.46%136.64M804.28%60.65M38.97%4.95M-13.90%12.08M-55.47%7.63M-67.46%6.71M-51.18%3.56M-56.72%14.03M-2.50%17.13M
Total non current assets 23.17%1.52B36.87%1.39B22.34%1.24B37.55%1.37B28.71%1.23B6.11%1.01B7.21%1.02B8.40%994.18M12.25%958.86M14.52%953.96M
Total assets 2.60%3.05B2.65%3.11B8.06%3.23B11.14%3.17B33.24%2.98B47.85%3.03B46.81%2.98B45.54%2.86B22.51%2.23B13.15%2.05B
Liabilities
Current liabilities
Short term loan -41.00%195.87M-33.02%246.18M15.18%394.23M36.34%372.16M74.74%332M--367.52M--342.27M--272.97M--190M----
Notes payable and accounts payable 4.02%121.48M2.78%167.84M-33.47%97.08M1.29%145.82M-24.72%116.79M-16.08%163.3M-11.61%145.92M2.24%143.96M14.55%155.14M19.81%194.6M
-Accounts payable 4.02%121.48M2.78%167.84M-33.47%97.08M1.29%145.82M-24.72%116.79M-16.08%163.3M-11.61%145.92M2.24%143.96M14.55%155.14M19.81%194.6M
Contract liabilities 12.89%11.36M11.47%9.7M20.18%10.55M8.37%8.98M26.66%10.06M-3.39%8.7M-16.19%8.78M-2.85%8.28M-28.42%7.94M4.09%9.01M
Advance receipts 50.57%1.18M27.93%1.45M-17.11%1.35M50.17%1.13M-66.79%780.61K-32.24%1.13M132.81%1.63M-30.40%751.68K--2.35M--1.67M
Salaries payable -12.81%26M-8.70%22.42M-4.05%18.42M-9.32%29.09M3.83%29.81M5.02%24.56M7.03%19.2M13.50%32.08M21.10%28.71M23.26%23.38M
Taxs payable -3.08%8.4M-2.50%3.4M48.05%6.98M16.01%9.53M7.50%8.67M-60.63%3.49M37.04%4.71M100.04%8.22M-25.21%8.06M155.51%8.86M
Other payable (including interest and dividends) -0.58%2.74M-92.55%2.84M184.51%7.32M-6.35%5.36M-56.13%2.76M231.80%38.1M-55.30%2.57M-42.18%5.73M0.77%6.29M40.59%11.48M
-Dividend payable ----------------------35.07M----------------
-Other payable -----6.45%2.84M-------------73.59%3.03M-----42.18%5.73M----65.35%11.48M
Non current liabilities due within one year 6.28%10.43M5.94%10.68M44.81%7.92M147.88%12.08M66.50%9.81M91.89%10.09M7.99%5.47M-13.48%4.87M59.52%5.89M39.32%5.26M
Other current liabilities 6.94%1.2M9.57%1.07M16.18%1.15M9.90%1M29.13%1.12M-3.91%974.38K-14.92%986.58K-4.96%910K-19.67%865.64K-96.35%1.01M
Total current liabilities -26.02%378.65M-24.65%465.58M2.53%545.01M22.48%585.15M26.29%511.8M142.03%617.86M153.56%531.55M139.75%477.77M111.03%405.26M9.46%255.28M
Current liabilities
Bonds payable 6.46%358.05M6.46%352.01M-17.54%346.05M-17.55%340.19M269.06%336.33M269.41%330.64M372.79%419.67M371.00%412.59M0.83%91.13M-15.06%89.51M
Deferred tax liabilities 76.24%7.07M45.53%6.02M30.57%5.4M24.10%3.78M16.66%4.01M-13.81%4.13M2.10%4.14M-23.50%3.04M-21.28%3.44M-2.19%4.8M
Long term deferred income 18.13%50.6M25.36%49.31M12.77%46.11M21.03%49.98M19.51%42.83M0.51%39.33M17.61%40.89M8.04%41.3M76.73%35.84M82.50%39.13M
Lease liabilities 19.54%28.21M4.29%26.04M62.08%23.81M50.09%23.97M104.68%23.6M122.23%24.96M27.92%14.69M19.81%15.97M-7.53%11.53M-13.19%11.23M
Total non current liabilities 9.14%443.94M8.59%433.37M-12.10%421.38M-11.63%417.92M186.58%406.78M175.85%399.07M244.71%479.4M230.39%472.9M11.33%141.94M0.01%144.67M
Total liabilities -10.45%822.58M-11.60%898.96M-4.41%966.39M5.51%1B67.87%918.58M154.27%1.02B189.91%1.01B177.64%950.67M71.25%547.2M5.84%399.95M
Shareholders equity
Paid-in capital -1.78%198.24M0.00%201.83M2.34%201.83M2.35%201.83M2.35%201.83M2.35%201.83M29.30%197.21M29.32%197.2M29.46%197.2M30.06%197.2M
Other equity instruments -0.00%69.77M-0.00%69.77M-21.30%69.77M-21.30%69.77M269.98%69.77M269.99%69.77M369.69%88.65M367.54%88.66M-5.33%18.86M-20.25%18.86M
Capital reserve funds -16.72%804.52M0.00%966.03M12.81%966.03M12.82%966.03M12.84%966.03M12.84%966.02M-4.93%856.3M-4.89%856.25M-4.35%856.12M-2.19%856.12M
Surplus reserve funds 8.90%100.93M8.90%100.93M8.90%100.93M8.90%100.93M19.92%92.68M19.92%92.68M19.92%92.68M19.92%92.68M15.18%77.29M15.18%77.29M
Retained profit 17.08%1.02B21.93%998.33M19.76%1.05B19.49%974.77M26.98%867.9M28.86%818.78M30.58%878.38M32.93%815.77M33.99%683.52M32.91%635.4M
Less:Treasury stock ----0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.12%165.11M-13.96%165.11M
Other composite income 66.15%42.29M40.48%35.96M30.91%33.76M14.91%23.06M34.35%25.45M-4.24%25.6M-4.39%25.79M-9.20%20.07M-21.85%18.94M-2.09%26.73M
Shareholders equity without minority interests 8.42%2.23B9.86%2.21B14.45%2.26B13.95%2.17B22.04%2.06B22.05%2.01B17.22%1.97B17.65%1.91B12.17%1.69B15.05%1.65B
Minority interests ---------------------------------24.53%388.55K--547.48K
Total shareholder equity 8.42%2.23B9.86%2.21B14.45%2.26B13.95%2.17B22.01%2.06B22.01%2.01B17.18%1.97B17.62%1.91B12.15%1.69B15.08%1.65B
Total liabilityies and equity 2.60%3.05B2.65%3.11B8.06%3.23B11.14%3.17B33.24%2.98B47.85%3.03B46.81%2.98B45.54%2.86B22.51%2.23B13.15%2.05B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data